ER-, HER2-, PR- breast Cancer genome sequencing
ER-, HER2-, PR- breast Cancer genome sequencing
- 27/05/2015
- 6 samples
- DAC: EGAC00001000010
- Technology: Illumina Genome Analyzer II
http://www.icgc.org/icgc/goals-structure-policies-guidelines/e1-informed-consent-access-and-ethical-oversight
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001000197 | Cancer Genomics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.